Attached files
| file | filename |
|---|---|
| EX-99.1 - NEPHROS INC | v209615_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported) January 31, 2011
|
NEPHROS, INC.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Delaware
|
|
(State
or other jurisdiction of
incorporation)
|
|
001-32288
|
13-3971809
|
|
|
(Commission
File Number)
|
(IRS
Employer ID
Number)
|
|
41 Grand Avenue, River Edge, New
Jersey
|
07661
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant's telephone number, including area code
(201) 343-5202
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
8.01
|
Other
Events.
|
On
January 31, 2011, Nephros, Inc. announced that the registration statement filed
for its previously announced rights offering was declared effective on January
31, 2011 by the Securities and Exchange Commission. A copy of the
press release announcing the effectiveness of the registration statement for the
rights offering is included as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated herein by reference.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
|
|
(d)
|
Exhibits
|
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
Release dated January 31, 2011.
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
| Nephros, Inc. | ||
|
By:
|
/s/
Gerald J. Kochanski
|
|
|
Dated: January
31, 2011
|
Gerald
J. Kochanski
|
|
|
Chief
Financial
Officer
|
||